Your browser doesn't support javascript.
loading
Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts.
Short, Nicholas J; Jabbour, Elias; Albitar, Maher; de Lima, Marcos; Gore, Lia; Jorgensen, Jeffrey; Logan, Aaron C; Park, Jae; Ravandi, Farhad; Shah, Bijal; Radich, Jerald; Kantarjian, Hagop.
Afiliação
  • Short NJ; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Albitar M; NeoGenomics Laboratories, Inc., Aliso Viejo, California.
  • de Lima M; University Hospitals, Cleveland, Ohio.
  • Gore L; Children's Hospital Colorado and University of Colorado Cancer Center, Aurora, Colorado.
  • Jorgensen J; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Logan AC; University of California San Francisco, San Francisco, California.
  • Park J; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ravandi F; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shah B; Moffitt Cancer Center, Tampa, Florida.
  • Radich J; Fred Hutchinson Cancer Research Center, Seattle, Western Australia.
  • Kantarjian H; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Am J Hematol ; 94(2): 257-265, 2019 02.
Article em En | MEDLINE | ID: mdl-30394566

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article